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that for ‘general immune system stimulation’ she had been 
drinking Noni juice, a Polynesian herbal remedy made from 
a tropical fruit  (Morinda citrifolia) , during the past 4 weeks. 
After cessation of the Noni juice ingestion, her transaminase 
levels normalized quickly and were in the normal range 
within 1 month.  Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 The use of complementary and alternative medicine, 
in particular herbal products and dietary supplements, is 
rapidly growing in Europe and in the United States  [1] . 
Since such products are usually labeled as dietary supple-
ments, only minor requirements for consumer’s safety 
are required before entering the market. 
 Noni juice, a dietary supplement, is an increasingly 
popular herbal drink which is currently distributed by 
several companies worldwide. One of those companies 
has been noted as ‘one of the fastest-growing private com-
panies in America and less than ten private companies in 
the history of the world were able to equal this company’s 
first six years of growth’ [http://www.tahitiannoni.com/
united_states/english/public/company]. This suggests in-
creasing consumption of Noni juice in the near future. 
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 Abstract 
 A 24-year-old female patient presented to her community 
hospital with mild elevations of serum transaminase and bil-
irubin levels. Because of multiple sclerosis, she was treated 
with interferon beta-1a for 6 weeks. After exclusion of viral 
hepatitis due to hepatitis A–E, interferon beta-1a was with-
drawn under the suspicion of drug-induced hepatitis. One 
week later, she was admitted again to her community hospi-
tal with severe icterus. The transaminase and bilirubin levels 
were highly elevated, and a beginning impairment of the 
liver synthesis was expressed by a reduced prothrombin 
time. The confinement to our department occurred with a 
fulminant hepatitis and the suspicion of beginning acute liv-
er failure. There was no evidence for hepatitis due to poten-
tially hepatotoxic viruses, alcoholic hepatitis, Budd-Chiari 
syndrome, hemochromatosis, and Wilson’s disease. In her 
serum there were high titers of liver-kidney microsomal type 
1 autoantibody; the serum gamma globulin levels were in 
the normal range. Fine-needle aspiration biopsy of the liver 
ruled out an autoimmune hepatitis but showed signs of 
drug-induced toxicity. During the interview, she admitted 
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 The Noni fruit was introduced in the Pacific area near-
ly 2,000 years ago and is one of the most commonly used 
and appreciated remedies in local traditional medicine 
for a variety of disorders  [2] . Apart from scanty preclini-
cal data, efficacy and safety of Noni juice were not vali-
dated in controlled clinical trials. Here, we report a pa-
tient presenting with subacute liver failure most likely 
related to the ingestion of high amounts of Noni juice. 
 Case Report 
 A 24-year-old female patient presented to her community hos-
pital with jaundice. On admission the alanine aminotransferase 
level was elevated to 1,538 U/l, that of bilirubin to 5.25 mg/100 ml, 
and that of   -glutamyltransferase to 110 U/l. After ruling out viral 
hepatitis A–E by serological testing, there was a suspicion of drug-
induced hepatitis due to interferon beta-1a (IFN). The patient had 
been treated with IFN for 10 weeks after the diagnosis of multiple 
sclerosis had been established, following an episode of inflamma-
tion of the optic nerve. After 4 weeks of IFN therapy, a routine 
laboratory examination revealed normal liver enzyme values. 
Nevertheless, IFN was initially suspected of causing her hepatitis 
and was, therefore, withdrawn. 
 One week after IFN withdrawal, the patient was examined 
again, with a dramatic increase of her liver enzyme levels (biliru-
bin 43.5 mg/100 ml, aspartate aminotransferase 2,818 U/l, ala-
nine aminotransferase 3,648 U/l). Thus, she was referred to our 
tertiary liver unit with the diagnosis of subacute liver failure. 
 Physical examination revealed a patient with severe jaundice; 
apart from this, the physical examination was inconspicuous. An 
ultrasound scan of the liver ruled out intra- or extrahepatic bile 
duct obstruction as well as vascular abnormalities or focal le-
sions. 
 We found no evidence for viral hepatitis A–E or other poten-
tially hepatotoxic viruses, alcoholic hepatitis, Budd-Chiari syn-
drome, hemochromatosis, or Wilson’s disease. The most remark-
able laboratory finding was an increased titer for liver-kidney 
 microsomal autoantibody type 1 (1:  3,840), with no other autoan-
tibodies detectable. However, liver biopsy did not reveal evidence 
for an autoimmune disease. There were confluent necroses of 
periportal and intralobular hepatocytes, lymphoplasmacellular 
and neutrophil inflammation, canalicular cholestasis, and mod-
erate fibrosis ( fig. 1 ). This pattern was highly suspicious for drug-
induced hepatitis. Furthermore, the autoimmune hepatitis score 
 [3] including histology summed up to 5 points, rating the diagno-
sis of autoimmune hepatitis as unlikely. 
 At this point, we took an extended medical history and asked 
the patient about any recent changes of her dietary habits in detail. 
Now she reported that she had been drinking Noni juice for 4 
weeks for ‘general immunostimulation’. We convinced the patient 
to immediately stop the consumption of Noni juice. Thereafter, 
the transaminase levels fell rapidly and were within the normal 
range after 1 month ( fig. 2 ). In summary, we diagnosed a drug-
induced hepatitis due to ingestion of Noni juice. 
 Discussion 
 Hepatotoxicity due to herbal remedies is a rare, but 
well-known adverse event  [4] . Since most of these herbal 
remedies are dietary supplements, only few requirements 
are necessary to launch such products onto the market. 
Scarcely a complete analysis of all ingredients is available, 
and a definitive characterization of pharmacologically 
active as well as toxic compounds is difficult or even im-
possible. Due to nonstandardized manufacturing proce-
dures and naturally occurring variability, the composi-
tion of compounds varies in most of the preparations. 
These issues also apply to Noni juice. A number of com-
pounds was identified, two of them having the potential 
for being hepatotoxic  [2] , but a complete analysis is lack-
ing. The first group comprises the anthraquinones (like 
nordamnacanthal, morindone, rubiadin, rubiadin-1-
methyl ether, anthraquinone glycoside) which are candi-
dates for having a dose-dependent hepatotoxicity. The 
second group which was suspected also for having idio-
syncratic hepatotoxic potential are the coumarins, e.g., 
scopoletin  [2] . Very recently, 3 cases of severe hepatitis 
were reported demonstrating potential hepatotoxicity of 
Noni juice  [5, 6] ( table 1 ). Since there are millions of Noni 
juice consumers, idiosyncratic hepatotoxicity seems more 
likely to be the problem. Moreover, the high titers of au-
toantibodies of the liver-kidney microsomal type in our 
patient may be a clue to this type of drug reaction, since 
 Fig. 1. Representative liver biopsy specimen, revealing periportal 
and intralobular hepatocyte necrosis, mixed inflammatory reac-
tion, and prominent canalicular cholestasis. HE.  ! 400. 
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autoantibodies were reported in hepatotoxicity induced 
by other drugs  [7] . We, therefore, conclude that in our 
patient Noni juice induced an idiosyncratic hepatitis. 
 Interactions between other herbal products and syn-
thetic drugs are well known. For example, St. John’s wort 
 (Hypericum perforatum) interacts with numerous con-
ventional drugs, including ciclosporin, simvastatin, and 
others  [8] . Thus, it seems quite possible that Noni juice 
worsened a preexisting liver damage due to IFN; hepato-
toxicity of IFN treatment has been reported before in a 
patient with multiple sclerosis  [9] . In another report  [3] , 
a preexisting liver damage, possibly due to Chinese herb-
al mix and acetaminophen, was worsened after the inges-
tion of Noni juice. Thus, in addition to the potential of 
damaging a healthy liver, synergistic mechanisms of hep-
atotoxicity due to Noni juice are likely. 
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 Table 1. Reports on the hepatotoxicity of Noni juice 
Gender Age
years
Concomitant
medication
Amount of Noni Duration of
ingestion
Delay between
ingestion and
onset of symptoms
Laboratory values
(maximum noted)
Refer-
ence
Male 45 none 1 glass/day ‘few weeks’ ‘few weeks’ AST 604 U/l 6
ALT 1,995 U/l
GGT 539 U/l
bilirubin 0.82 mg/dl
Male 29 acetaminophen, 1.5 liters within 
3 weeks prior to
admission
not stated not stated AST 1,557 U/l 5
Chinese herbal ALT 626 U/l
mix bilirubin 45.3 mg/dl
Female 62 none 2 liters 4 months 4 weeks AST 1,455 U/l 5
ALT 2,381 U/l
GGT 241 U/l
bilirubin 2.9 mg/dl
Female 24 interferon beta-1a 1–1.5 liters 4 weeks 3 weeks AST 2,818 U/l this 
studyALT 3,648 U/l
bilirubin 43.5 mg/100 ml
AST = Aspartate aminotransferase; ALT = alanine aminotransferase; GGT = -glutamyltransferase.
 
 Fig. 2. Serum concentrations of alanine 
aminotransferase (U/l;  U ) and bilirubin 
(mg/100 ml;  f ) during and after cessation 
of the IFN therapy and ingestion of Noni 
juice. 
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 In summary, the increasing popularity of Noni juice 
adds another task to gastroenterologists and hepatolo-
gists: patients with unexplained elevation of liver enzyme 
levels or liver failure should be questioned carefully about 
the ingestion of Noni juice as well as other herbal reme-
dies, and patients with preexisting liver impairment 
should be advised not to consume Noni juice. Quite like-
ly with a growing awareness, the number of patients with 
diagnosed liver injury due to ingestion of Noni juice will 
increase. 
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